Article

Silodosin — a safer alpha-blocker targeting benign prostatic hyperplasia

Published in: South African Family Practice
Volume 57 , issue 5 : Entrepreneurship and Africa’s Cultural Context , 2024 , pages: 291–292

DOI: 10.1080/20786190.2014.978099

Author(s): Karen Koch Private practice GP and freelance medical writer, South Africa,

Keywords: alpha-1A receptor inhibitor, Benign prostatic hypertrophy, BPH, lower urinary tract symptoms,

Download full text Get new issue alerts

Abstract

Silodosin is a specific alpha-1A receptor inhibitor newly available in South Africa. It offers a real solution to symptoms of BPH especially in those patients with moderate prostate enlargement experiencing nocturia, frequency and incomplete voiding.

« A blank page: feedback from first referral hospitals to primary health care clinics

Remote clinical support by telephone for rural district hospital medical officers in the Eastern Cape »

Article

Silodosin — a safer alpha-blocker targeting benign prostatic hyperplasia

Abstract

Get new issue alerts for South African Family Practice

Latest news

Latest articles